REQUEST A DEMO
Total
USD $0.00
Search more companies

Inmunopharma S.A.S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Inmunopharma S.A.S Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Inmunopharma S.A.S is a company based in Colombia, with its head office in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on July 27, 2018. It currently has a total number of 24 (2025) employees. In 2024, the company reported a net sales revenue increase of 35.31%. Its total assets grew by 72.41% over the same period. In 2024, Inmunopharma S.A.S’s net profit margin increased by 26.84%.

Headquarters
Calle 85 A 28 B 34
Bogota D.C.; Bogota D.C; Postal Code: 0820

Contact Details: Purchase the Inmunopharma S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Inmunopharma S.A.S report to view the information.
Financial Auditors:
Purchase the Inmunopharma S.A.S report to view the information.
Incorporation Date:
July 27, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Inmunopharma S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
35.31%
Total operating revenue
35.31%
Operating profit (EBIT)
37.47%
Net Profit (Loss) for the Period
11.39%
Total Assets
72.41%
Total Equity
1294.25%
Operating Profit Margin (ROS)
34.99%
Net Profit Margin
26.84%
Return on Equity (ROE)
3828.55%
Quick Ratio
0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?